Keywords: Valeant on acquisition trail againaleant Pharma, Pele Nova Biotecnologia, Brazil, Equity stake, M&A, Regederm, Wound healing

Valeant on acquisition trail again

Article | 12 March 2012

Print This

In a third acquisition deal announced so far this year, Canada-based Valeant Pharmaceuticals International (TSX: VRX) said yesterday that it ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in